Equities

Carlyle Group Inc

Carlyle Group Inc

Actions
  • Price (EUR)43.60
  • Today's Change0.80 / 1.87%
  • Shares traded20.00
  • 1 Year change+57.03%
  • Beta--
Data delayed at least 15 minutes, as of Mar 28 2024 15:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

The Carlyle Group Inc. is a global investment company. The Company operates through three segments: Global Private Equity, Global Credit, and Global Investment Solutions. The Global Private Equity segment advises the Company’s buyout, middle market and growth capital funds, its U.S. and internationally focused real estate funds, and its infrastructure and natural resources funds. The segment also includes the NGP Carry Funds advised by NGP. The Global Credit segment advises funds and vehicles that pursue investment strategies including loans and structured credit, direct lending, opportunistic credit, distressed credit, aircraft financing and servicing, infrastructure debt, insurance solutions and global capital markets. The Global Investment Solutions segment advises global private equity programs and related co-investment and secondary activities. The Company has investment professionals in over 28 offices across four continents. It also focuses on private student loan portfolio.

  • Revenue in USD (TTM)2.96bn
  • Net income in USD-608.40m
  • Incorporated2011
  • Employees2.20k
  • Location
    Carlyle Group IncC/O The Carlyle Group1001 Pennsylvania Avenue, N.W.WASHINGTON 20004United StatesUSA
  • Phone+1 (202) 729-5626
  • Fax+1 (302) 655-5049
  • Websitehttps://www.carlyle.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CG:NSQ since
announced
Transaction
value
GBTEC Software & Consulting AGDeal completed23 Nov 202323 Nov 2023Deal completed45.74%--
Locabox SASDeal completed18 Oct 202318 Oct 2023Deal completed56.93%--
Medtronic Plc-Medical Device Businesses(2)Rumoured29 Sep 202329 Sep 2023Rumoured56.15%--
Evolution Funding LtdDeal completed25 Jul 202325 Jul 2023Deal completed36.79%--
Prophecy SASAnnounced03 Jul 202303 Jul 2023Announced47.75%--
Data delayed at least 15 minutes, as of Mar 28 2024 16:27 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.